HSR24-147: Non-Optimal Treatment in Early-Line Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Tyrosine Kinase Inhibitors (TKI): A Claims Data Analysis.

Journal of the National Comprehensive Cancer Network : JNCCN(2024)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要